Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

moxifloxacin Ophthalmic Solution [Vigamox]

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BackgroundDry eye disease (DED) is a prevalent complication of diabetes and presents as reduced tear production and/or increased… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2017
2017
The objective of this research was to develop and evaluate an ocular insert for the controlled drug delivery of moxifloxacin… 
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2017
2017
In addition to the breadth of activity of antibacterial medications as well as to their pharmacokinetic and pharmacodynamic… 
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2015
2015
In addition to the spectrum of antibacterial activity of antimicrobial medicines and their pharmacokinetic and pharmacodynamic… 
2009
2009
ZusammenfassungHintergrundDie Wirksamkeit von Moxifloxacin (Vigamox®) umfasst die meisten für bakterielle Endophthalmitiden…